Silibinin component for the treatment of hepatitis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/357 (2006.01) A61P 1/16 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2703834

The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.

La présente invention concerne l'utilisation d'un composant de silibinine pour la production d'un médicament qui est adapté pour une administration parentérale destinée au traitement d'une hépatite virale, de préférence de l'hépatite B ou C, en particulier pour la réduction de la charge virale. De préférence, le médicament ne contient aucune silidianine et/ou aucune silichristine et/ou aucune isosilibinine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Silibinin component for the treatment of hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Silibinin component for the treatment of hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Silibinin component for the treatment of hepatitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1413814

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.